Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

STIMUPLEX PEN

K-Number: K061983 · 2006-11-21

ApplicantStockert GmbH
Decision Date2006-11-21
Product CodeBXN
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

STIMUPLEX PEN is the device name listed in this FDA 510(k) record. The listed applicant is Stockert GmbH. It received FDA 510(k) clearance on 2006-11-21 under 510(k) number K061983. The device is classified under product code BXN. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the STIMUPLEX PEN?

STIMUPLEX PEN is a medical device that received FDA 510(k) clearance on 2006-11-21. The listed applicant is Stockert GmbH. The 510(k) number is K061983.

When did STIMUPLEX PEN receive FDA 510(k) clearance?

STIMUPLEX PEN received FDA 510(k) clearance on 2006-11-21, under 510(k) number K061983.

Who is the listed applicant for STIMUPLEX PEN?

The FDA 510(k) record lists Stockert GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for STIMUPLEX PEN?

The FDA product code for STIMUPLEX PEN is BXN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Stockert GmbH as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: BXN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑